Toshiro Shirakawa, Junya Furukawa, Yasumasa Kakei, Hideto Ueki, Takuto Hara, Jun Teishima, Nobuyuki Hinata, Hideaki Miyake, Masato Fujisawa. "A phase 1, first-in-human, open label, dose escalating study of B440, an oral cancer vaccine using a WT1-expressing
            <i>Bifidobacterium</i>
            , in patients with advanced urothelial cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps883